Filter
431
Filtered Results: 431
Text search:
drug
stability
testing
Featured
Recommendations
37
New Publications
113
Language
Document type
No document type
283
Guidelines
54
Studies & Reports
53
Manuals
23
Strategic & Response Plan
9
Situation Updates
3
Fact sheets
3
Training Material
2
Infographics
1
Countries / Regions
India
20
Kenya
15
Uganda
14
Liberia
13
South Africa
13
Nigeria
10
Zambia
10
Tanzania
10
Ethiopia
9
Western and Central Europe
9
Sierra Leone
8
Malawi
8
Global
8
Rwanda
7
Zimbabwe
6
Bangladesh
6
Asia
6
Cambodia
5
Namibia
5
Ukraine
5
Nepal
4
Botswana
4
Eastern Europe
4
Congo, Democratic Republic of
3
Ghana
3
South Sudan
3
Mozambique
3
Middle East and North Africa
3
Latin America and the Carribbean
3
Guinea
2
Senegal
2
USA
2
Lesotho
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Africa
2
Russia
2
Burkina Faso
1
Philippines
1
Iraq
1
Syria
1
China
1
Indonesia
1
Malaysia
1
Sudan
1
Colombia
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Albania
1
Moldova
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
174
Clinical Guidelines
40
Pharmacy & Technologies
18
Public Health
13
Women & Child Health
13
Key Resources
10
Capacity Building
6
Toolboxes
HIV
55
Mental Health
37
TB
33
Pharmacy
29
COVID-19
24
AMR
16
Ebola
11
Rapid Response
10
NTDs
10
Caregiver
6
Conflict
4
Refugee
4
Planetary Health
4
Health Financing Toolbox
4
Natural Hazards
3
Global Health Education
3
NCDs
3
Specific Hazards
2
Disability
1
Cholera
1
Zika
1
Social Ethics
1
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag...
Compounding of pharmaceutical formulations remain as the core skill of pharmacists and this manual is produced to include well referenced recipes that are easy to prepare, use readily available ingredients, have the longest expiry date possible and when necessary, pr...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
